Cefoxitin sodium

This classification denotes a cephalosporin antibiotic with the molecular formula C16H16N3O7S2.Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Q68050H03T, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-(((aminocarbonyl)oxy)methyl)-7-methoxy-8-oxo-7-((2-thienylacetyl)amino)-, sodium salt, (6r-cis)- but more generally known as cefoxitin sodium, which bears US NIH Compound Identifier 36551. European Medicines Agency schedules Cefoxitin sodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB13277MIG. Most nations, for tariff and trade purposes, schedule cefoxitin sodium under HS 29419000 and SITC 54139. As of Q4 2014, CEFOXITIN SODIUM remains US FDA's Preferred Term for this commodity. Cefoxitin sodium bears US NLM identifiers UMLS ID C0701380 and NCI Concept Code C28915. SMILES: CO[C@@]1([C@@H]2N(C1=O)C(=C(CS2)COC(=O)N)C(=O)[O-])NC(=O)CC3CCCS3.[NA+].